Stay updated on Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Two new study sites were added: Chongqing, China (400042) and Thane, India (411107). The list also shows removal/rename of Yuzhong District (Chongqing 400042) and Thāne (411107).
    Difference
    0.1%
    Check dated 2025-12-27T18:25:44.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Locations section updated with an expanded list of US states and Canadian provinces. - Page revision updated to v3.3.3; HHS Vulnerability Disclosure section removed.
    Difference
    0.7%
    Check dated 2025-12-19T13:00:38.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    - Revision: v3.3.2 is now displayed, replacing Revision: v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-28T00:31:59.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Added the labels 'Last Update Posted (Estimated)' and 'Revision: v3.3.1', and removed 'Last Update Posted' and 'Revision: v3.2.0'; this is a minor UI/versioning update that does not modify the study data or participation details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-20T22:29:19.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    A new trial site was added: Tainan, Taiwan, 704, with a Last Update Posted entry on 2025-11-06. The prior listing for Tainan City, Taiwan, 704 was removed on 2025-10-28.
    Difference
    0.2%
    Check dated 2025-11-13T16:52:10.000Z thumbnail image
  8. Check
    67 days ago
    Change Detected
    Summary
    Recent changes appear to be updates to study record dates (e.g., 2025-10-28, 2025-10-09, 2025-10) and do not alter core content such as design, eligibility, or endpoints. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-10-30T11:14:52.000Z thumbnail image

Stay in the know with updates to Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab & Lazertinib Combo in EGFR+ NSCLC Clinical Trial page.